دورية أكاديمية
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
| العنوان: | Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. |
|---|---|
| المؤلفون: | Lipson, D. A. inc., Halpin, David M |
| بيانات النشر: | NEJM |
| سنة النشر: | 2018 |
| المجموعة: | RD&E Research Repository (Royal Devon and Exeter NHS Foundation Trust) |
| مصطلحات موضوعية: | Wessex Classification Subject Headings::Respiratory medicine, Administration, Inhalation, Adrenergic beta-Agonists, Adult, Aged, Androstadienes, Benzyl Alcohols, Bronchodilator Agents, Chlorobenzenes, Double-Blind Method, Drug Administration Schedule, Drug Combinations, Dyspnea, Female, Glucocorticoids, Hospitalization, Humans, Intention to Treat Analysis, Male, Middle Aged, Muscarinic Antagonists, Pulmonary Disease, Chronic Obstructive, Quality of Life, Quinuclidines |
| الوصف: | The benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA), as compared with dual therapy (either inhaled glucocorticoid-LABA or LAMA-LABA), are uncertain. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 1533-4406 29668352 |
| العلاقة: | Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. 2018, 378 (18):1671-1680 N. Engl. J. Med.; http://hdl.handle.net/11287/620707Test; The New England journal of medicine |
| DOI: | 10.1056/NEJMoa1713901 |
| الإتاحة: | https://doi.org/10.1056/NEJMoa1713901Test http://hdl.handle.net/11287/620707Test |
| حقوق: | Archived with thanks to The New England journal of medicine |
| رقم الانضمام: | edsbas.985A9F66 |
| قاعدة البيانات: | BASE |
| تدمد: | 15334406 29668352 |
|---|---|
| DOI: | 10.1056/NEJMoa1713901 |